Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

CRD007 for the Treatment of Duchenne Muscular Dystrophy, Becker Muscular Dystrophy and Symptomatic Carriers

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
RSPR Pharma AB
ClinicalTrials.gov Identifier:
NCT01540604
First received: February 23, 2012
Last updated: October 1, 2012
Last verified: October 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: No date given